Marshall Wace’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Sell
22,572
-77,827
-78% -$5.53M ﹤0.01% 1951
2025
Q4
$6.97M Buy
+100,399
New +$7.05M 0.01% 1009
2024
Q4
Sell
-10,900
Closed -$1.26M 2704
2024
Q3
$1.26M Sell
10,900
-2,469
-18% -$258K ﹤0.01% 1555
2024
Q2
$1.27M Buy
+13,369
New +$1.21M ﹤0.01% 1578
2021
Q4
Sell
-99,334
Closed -$11.2M 3974
2021
Q3
$11.2M Buy
+99,334
New +$10.7M 0.05% 491
2020
Q4
Sell
-9,697
Closed -$699K 1953
2020
Q3
$699K Buy
+9,697
New +$771K ﹤0.01% 1142
2020
Q2
Sell
-3,016
Closed -$217K 1661
2020
Q1
$217K Buy
+3,016
New +$219K ﹤0.01% 1165
2019
Q3
Sell
-20,351
Closed -$1.19M 1739
2019
Q2
$1.19M Sell
20,351
-17,416
-46% -$992K 0.01% 889
2019
Q1
$2.18M Sell
37,767
-114,623
-75% -$6.19M 0.02% 711
2018
Q4
$7.73M Buy
152,390
+108,966
+251% +$5.47M 0.08% 312
2018
Q3
$2.33M Buy
+43,424
New +$2.22M 0.02% 647
2015
Q3
Sell
-116,022
Closed -$2.6M 963
2015
Q2
$2.6M Buy
+116,022
New +$2.55M 0.03% 412

Other funds holding EXPO

Marshall Wace's EXPO Position: Q1 2026 in Review

Marshall Wace reduced its Exponent (EXPO) stake by 78% in Q1 2026, selling an estimated $5.53M and leaving 22,572 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

Marshall Wace first reported a position in EXPO in Q2 2015 and has held it in 12 quarters since. The position peaked at $11.2M in Q3 2021. 360 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • Marshall Wace held 22,572 shares of Exponent worth $1.47M as of Q1 2026.
  • Marshall Wace sold 77,827 Exponent shares in Q1 2026, an estimated $5.53M.
  • Exponent made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1951 holding.
  • Marshall Wace first reported a position in Exponent in Q2 2015 and has held it in 12 quarters since.
  • Marshall Wace's Exponent position peaked at $11.2M in Q3 2021.
  • 360 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.